ARS announces the three winners of its "call for innovators"

[ad_1]

The ARS Ile-com-France launched in early May a "call for innovators" in order to bring out solutions developed by actors in the field to improve the service rendered to users by relying on digital tools, recalls- we.

Out of 155 projects received, 10 were supported during an intermediate "pre-incubation" phase. After this stage, a jury made up of representatives from the ARS, the regional conference on health and autonomy (CRSA) Ile-com-France and Beta.gouv.com (network of incubators for start-ups in 'State) selected three projects "on the basis of criteria linked to the impact of the public policy problem targeted, the orientation of the solution towards the user, the size of the population targeted by the solution, its replicability at the level national and the capacity of the carrier to carry the project ".

The three projects selected are:

• Access to abortion for all, worn by representatives of the Revho association (Network between the city and the hospital for orthogenics), in Paris. The proposed digital solution is the complete overhaul of IVGlesadresses.org.

• capacitee, supported by a doctor from a care, support and prevention center in addiction (Csapa) of the association CaPASSCité in Montreuil (Seine-Saint-Denis). The project includes the creation of a digital solution (offering a self-Review and a consumption monitoring book) and the reorganization of the work of the Csapa in order to reduce the waiting times between a request for treatment by a patient and a first contact with an addiction professional.

• MonSuiviPsy, worn by a doctor from EPS Barthélemy-Durand, in Etampes (Essonne). This project provides a platform dedicated to patients with psychiatric disorders, giving them the possibility of monitoring the development of their symptoms daily between two consultations to facilitate the identification of the right treatment.

These projects enter an incubation phase of 6 months, during which the carriers concerned are released from their usual tasks, while retaining the same terms of remuneration. Those "having demonstrated their impact" will be able to receive "additional means to support the larger-scale deployment of the solution developed", specifies the ARS.

[ad_2]